Evaluation of HER2/neu oncoprotein in serum and tissue samples of women with breast cancer: Correlation with clinicopathological parameters
Open Access
- 31 December 2010
- journal article
- research article
- Published by Elsevier BV in The Breast
- Vol. 19 (6), 489-492
- https://doi.org/10.1016/j.breast.2010.05.012
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancerBreast Cancer Research and Treatment, 2008
- Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survivalAnnals of Oncology, 2008
- Predicting Tissue HER2 Status Using Serum HER2 Levels in Patients with Metastatic Breast CancerClinical Chemistry, 2006
- Serum EGFR levels and efficacy of trastuzumab-based therapy in patients with metastatic breast cancerEuropean Journal of Cancer, 2006
- Evaluation of the Quantitative Analytical Methods Real-Time PCR for HER-2 Gene Quantification and ELISA of Serum HER-2 Protein and Comparison with Fluorescence in Situ Hybridization and Immunohistochemistry for Determining HER-2 Status in Breast Cancer PatientsClinical Chemistry, 2005
- Potential Clinical Utility of Serum HER-2/neu Oncoprotein Concentrations in Patients with Breast CancerClinical Chemistry, 2003
- A comparison of five immunohistochemical biomarkers and HER‐2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early‐onset breast carcinomaCancer, 2003
- c‐erbB‐2 and ras expression levels in breast cancer are correlated and show a co‐operative association with unfavorable clinical outcomeInternational Journal of Cancer, 1991
- Neu-Protein Overexpression in Breast CancerThe New England Journal of Medicine, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987